2008 to 2022 Saw Rise in Industry-Sponsored Adult Cancer Clinical Trials
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 15, 2024 -- In the United States, there is a growing reliance on industry to conduct cancer clinical research, according to a study published online Sept. 27 in the Journal of Clinical Oncology.
Joseph M. Unger, Ph.D., from the Fred Hutchinson Cancer Center in Seattle, and colleagues evaluated cancer trial enrollment patterns from 2008 to 2022 using ClinicalTrials.gov data to estimate the ratio of enrollments attributable to industry versus federal sponsors.
The researchers identified 26,080 studies and determined the estimated enrollment ratio from 2018 to 2022 for all industry-sponsored versus federally sponsored trials was 8.1. The ratio increased from 4.8 during 2008 to 2012 to 9.6 during 2018 to 2022 for adult trials, while the ratio increased for trials in children from 0.7 to 2.3. Enrollment counts for federally sponsored trials were flat during the study period, despite increasing cancer incidence.
"We recognized that industry was playing an increasing role in cancer clinical research compared to decades ago. But we didn't realize the difference was this dramatic," Unger said in a statement. "Industry investment in cancer clinical research has accelerated precision oncology and cancer immunotherapy tremendously. However, with increased federal investment in cancer research as well, we could see even greater strides in treatment options for patients with cancer."
One author disclosed ties to AstraZeneca and Loxo/Lilly; another author disclosed ties to Agios.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
American Society of Clinical Oncology, May 31-June 3
The annual meeting of the American Society of Clinical Oncology was held from May 31 to June 3 in Chicago and hosted more than 35,000 participants, including clinicians...
Better Adherence to Antipsychotics Linked to Lower Vehicle Crash Risk
MONDAY, June 9, 2025 -- For drivers with schizophrenia, better adherence to antipsychotic medications is associated with lower motor vehicle crash risk, according to a study...
Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk
MONDAY, June 9, 2025 -- Early-life dog exposure may modify the genetic effect of the single nucleotide variant rs10214237 on atopic eczema (AE) via IL7R, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.